Sierra Oncology Successfully Transfers Sponsorship of SRA737 Clinical Trials
Go back to Sierra Oncology Successfully Transfers Sponsorship of SRA737 Clinical Trials| SARATOGA INVESTMENT CORP. NEW (NYSE: SAR) | Delayed: 18.34 -0.16 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.50 | 52 Week High | $19.55 | |||
| Open | $18.58 | 52 Week Low | $13.41 | |||
| Day High | $18.58 | P/E | 7.80 | |||
| Day Low | $18.30 | EPS | $2.35 | |||
| Volume | 77,201 | |||||
| (NASDAQ: SRRA) | Delayed: 54.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.99 | 52 Week High | $ | |||
| Open | $16.72 | 52 Week Low | $ | |||
| Day High | $54.99 | P/E | N/A | |||
| Day Low | $54.99 | EPS | $ | |||
| Volume | 276,343 | |||||
